Perioperative Patient Blood Management to Improve Outcomes

Anemia is common in elective surgery and is an independent risk factor for morbidity and mortality. Historical management of anemia has focused on the use of allogeneic blood transfusion but this in itself is not without risk. It too has been independently associated with morbidity and mortality, let alone the costs and relative shortage of this resource. In recognition of this, patient blood management (PBM) shifts the focus from the product to the patient and views the patient’s own blood as a resource that should be conserved and managed appropriately as a standard of care. It consists of 3 pillars: the optimization of red blood cell mass; reduction of blood loss and bleeding; and optimization of the patient’s physiological tolerance toward anemia. Integration of these 3 pillars in the form of multimodal care bundles and strategies into perioperative pathways should improve care processes and patient outcome. Preoperative anemia is most commonly caused by functional iron deficiency and should be treated with oral iron, intravenous iron, and/or recombinant erythropoietin. An individualized assessment of the thrombotic risk of discontinuing anticoagulant and antiplatelet medication should be balanced against the risk of perioperative bleeding. Neuraxial anesthetic techniques should be considered and minimally invasive surgery undertaken where appropriate. Cell salvage should be used if significant blood loss is anticipated and pharmacological treatments such as tranexamic acid and fibrin sealants have been shown to reduce blood loss. Point of care tests can guide the perioperative management of dynamic coagulopathy. Blood testing sampling should be performed only when indicated and when taken, sample volume and waste should be minimized. Restrictive blood transfusion thresholds and reassessment after single unit transfusion should be incorporated into clinical practice where appropriate. For PBM to become standard practice in routine surgical care, national health care quality change initiatives must set the agenda for change but the patient-centered approach to PBM should be delivered in a way that is also hospital centered. Characterization of the current practice of PBM at each hospital is crucial to facilitate the benchmarking of performance. Barriers to effective implementation such as lack of knowledge should be identified and acted on. Continuous audit of practice with a focus on transfusion rates and patient outcomes can identify areas in need of improvement and provide iterative feedback to motivate and inspire the main stakeholders.

[1]  S. Lemeshow,et al.  Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. , 2015, Critical care medicine.

[2]  G. Chertow,et al.  Update on adverse drug events associated with parenteral iron. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  Seth R Flaxman,et al.  A systematic analysis of global anemia burden from 1990 to 2010. , 2014, Blood.

[4]  Y. Okada,et al.  Enzyme-Controlling Medicines: Introduction , 1997, Seminars in thrombosis and hemostasis.

[5]  A. Moxey,et al.  Cell salvage for minimising perioperative allogeneic blood transfusion. , 2010, The Cochrane database of systematic reviews.

[6]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[7]  J. Minei,et al.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2002, The Journal of trauma.

[8]  J. Shah,et al.  Association between Perioperative Blood Transfusions and Clinical Outcomes in Patients Undergoing Bladder Cancer Surgery: A Systematic Review and Meta-Analysis Study , 2016, Journal of blood transfusion.

[9]  B. Chaitman,et al.  Liberal or restrictive transfusion in high-risk patients after hip surgery. , 2011, The New England journal of medicine.

[10]  P. Cabrales,et al.  Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions , 2004, Transfusion.

[11]  P. Meybohm,et al.  Patient Blood Management Bundles to Facilitate Implementation. , 2017, Transfusion medicine reviews.

[12]  Gabriel J Escobar,et al.  Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity , 2014, BMC Health Services Research.

[13]  Yanming Zhou,et al.  Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis , 2014, BMC Surgery.

[14]  J. Meier,et al.  Pillar III--optimisation of anaemia tolerance. , 2013, Best practice & research. Clinical anaesthesiology.

[15]  F. Stuber,et al.  Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. , 2008, The Journal of trauma.

[16]  P. Tartter,et al.  EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATE , 1982, The Lancet.

[17]  S. Mallett Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation , 2015, Seminars in Thrombosis & Hemostasis.

[18]  J. Powell,et al.  Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis , 2015, PloS one.

[19]  J. Dinardo,et al.  TEG and ROTEM: Technology and clinical applications , 2014, American journal of hematology.

[20]  G. Kouraklis,et al.  Comparison Between Minimally Invasive and Open Gastrectomy for Gastric Cancer in Europe: A Systematic Review and Meta-analysis , 2017, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[21]  Jørn Wetterslev,et al.  Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. , 2016, The Cochrane database of systematic reviews.

[22]  J. Stein,et al.  An Etiologic Profile of Anemia in 405 Geriatric Patients , 2014, Anemia.

[23]  Y. Yoo,et al.  Effect of Single Recombinant Human Erythropoietin Injection on Transfusion Requirements in Preoperatively Anemic Patients Undergoing Valvular Heart Surgery , 2011, Anesthesiology.

[24]  J. Lawson,et al.  Challenges for providing effective hemostasis in surgery and trauma. , 2004, Seminars in hematology.

[25]  G. Pelissero,et al.  Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. , 2012, The Annals of thoracic surgery.

[26]  Christopher L. Wu,et al.  Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. , 2006, Journal of clinical anesthesia.

[27]  T. Haas,et al.  Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? , 2015, British journal of anaesthesia.

[28]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[29]  D. Swinkels,et al.  Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. , 2015, Blood.

[30]  A. D. de Wolf,et al.  Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting: A Comparison With the Matched General Population , 2009, Circulation.

[31]  D. Francis,et al.  BLOOD TRANSFUSION AND TUMOUR GROWTH: EVIDENCE FROM LABORATORY ANIMALS , 1981, The Lancet.

[32]  T. B. Vaughan,et al.  Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. , 2009, Journal of the American College of Surgeons.

[33]  L. Goodnough,et al.  Objectives and limitations of bloodless medical care , 2006, Current opinion in hematology.

[34]  L. Goodnough,et al.  Patient Blood Management , 2012, Anesthesiology.

[35]  H. Kehlet,et al.  'Fit to fly': overcoming barriers to preoperative haemoglobin optimization in surgical patients. , 2015, British journal of anaesthesia.

[36]  P. Austin,et al.  Surgical outcomes and transfusion of minimal amounts of blood in the operating room. , 2012, Archives of surgery.

[37]  M. Levy,et al.  A Multifaceted Intervention to Improve Compliance With Process Measures for ICU Clinician Communication With ICU Patients and Families* , 2013, Critical care medicine.

[38]  P. Rehak,et al.  Blood use in elective surgery: the Austrian benchmark study , 2007, Transfusion.

[39]  J. García-Erce,et al.  Disorders of iron metabolism. Part II: iron deficiency and iron overload , 2010, Journal of Clinical Pathology.

[40]  P. Meybohm,et al.  Savoring every drop – Vampire or Mosquito? , 2014, Critical Care.

[41]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[42]  A. Handa,et al.  The role of cell salvage autotransfusion in abdominal aortic aneurysm surgery. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[43]  J. Dunne,et al.  Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. , 2002, The Journal of surgical research.

[44]  G. Horowitz,et al.  Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. , 1989, American journal of clinical pathology.

[45]  P. Meybohm,et al.  “Simplified International Recommendations for the Implementation of Patient Blood Management” (SIR4PBM) , 2017, Perioperative Medicine.

[46]  Rajvinder Singh,et al.  The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. , 2018, Annals of surgery.

[47]  M. Parker,et al.  Closed suction drainage for hip and knee arthroplasty. A meta-analysis. , 2004, The Journal of bone and joint surgery. American volume.

[48]  L. Leibovici,et al.  The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.

[49]  B. Gersh Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study , 2008 .

[50]  S. Farmer,et al.  Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). , 2013, Best practice & research. Clinical anaesthesiology.

[51]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[52]  S. Hohmann,et al.  Variation of Blood Transfusion in Patients Undergoing Major Noncardiac Surgery , 2013, Annals of surgery.

[53]  H. Gombotz,et al.  Patient Blood Management , 2013, Der Anaesthesist.

[54]  I. Roberts,et al.  Topical application of tranexamic acid for the reduction of bleeding. , 2013, The Cochrane database of systematic reviews.

[55]  D. Stoltzfus,et al.  The effect of arterial lines on blood-drawing practices and costs in intensive care units. , 1995, Chest.

[56]  Jie Li,et al.  Topical use of topical fibrin sealant can reduce the need for transfusion, total blood loss and the volume of drainage in total knee and hip arthroplasty: A systematic review and meta-analysis of 1489 patients. , 2016, International journal of surgery.

[57]  D. Spahn,et al.  Activity‐based costs of blood transfusions in surgical patients at four hospitals , 2010, Transfusion.

[58]  P. Metnitz,et al.  Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. , 2014, British journal of anaesthesia.

[59]  Tomas Ganz,et al.  Hepcidin and iron regulation, 10 years later. , 2011, Blood.

[60]  Lina Yu,et al.  Preoperative Acute Normovolemic Hemodilution for Minimizing Allogeneic Blood Transfusion: A Meta-Analysis , 2015, Anesthesia and analgesia.

[61]  A. Ashworth,et al.  Cell salvage as part of a blood conservation strategy in anaesthesia. , 2010, British journal of anaesthesia.

[62]  J. Marescaux,et al.  Short and long-term outcomes of laparoscopic compared to open liver resection for colorectal liver metastases. , 2016, Hepatobiliary surgery and nutrition.

[63]  C. McCollum,et al.  Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. , 2006, Health technology assessment.

[64]  A. Laupacis,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2001, The Cochrane database of systematic reviews.

[65]  Rajvinder Singh,et al.  The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery , 2016, Annals of surgery.

[66]  N. Blumberg,et al.  Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions , 1991, Transfusion.

[67]  J. Sterne,et al.  Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. , 2015, The Lancet. Haematology.

[68]  S. Hopewell,et al.  A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010 , 2013, BMJ Open.

[69]  P. Wouters,et al.  Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. , 2017, European journal of anaesthesiology.

[70]  G. Hare,et al.  Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? , 2013, Best practice & research. Clinical anaesthesiology.

[71]  C. Ori,et al.  Microbiologic contamination of intraoperative blood salvaged during liver transplantation. , 2007, Transplantation proceedings.

[72]  P. Tartter,et al.  Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. , 1986, American journal of surgery.

[73]  E. Unger,et al.  Erythropoiesis-stimulating agents--time for a reevaluation. , 2010, The New England journal of medicine.

[74]  E. Blackstone,et al.  Contemporary bloodletting in cardiac surgical care. , 2015, The Annals of thoracic surgery.

[75]  D. Triulzi,et al.  A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery , 1992, Transfusion.

[76]  S. Brister,et al.  Does the Use of Erythropoietin Reduce the Risk of Exposure to Allogeneic Blood Transfusion in Cardiac Surgery? A Systematic Review and Meta‐Analysis , 2006, Journal of cardiac surgery.

[77]  J. Cuenca,et al.  Very‐short‐term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients , 2013, Transfusion.

[78]  N. Davidson,et al.  Assessing the total costs of blood delivery to hospital oncology and haematology patients , 2006, Current medical research and opinion.

[79]  W. Lim,et al.  British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project , 2015, Thorax.

[80]  D. Wijeysundera,et al.  Risk Associated with Preoperative Anemia in Noncardiac Surgery: A Single-center Cohort Study , 2009, Anesthesiology.

[81]  L. Shieh,et al.  Improved blood utilization using real‐time clinical decision support , 2014, Transfusion.

[82]  P. Metnitz,et al.  Evaluation of clinical practice in perioperative patient blood management. , 2016, British journal of anaesthesia.

[83]  M. Murphy,et al.  Blood transfusion: summary of NICE guidance , 2015, BMJ : British Medical Journal.

[84]  H. Kehlet,et al.  International consensus statement on the peri‐operative management of anaemia and iron deficiency , 2017, Anaesthesia.

[85]  R. Habib,et al.  Effect of blood transfusion on long-term survival after cardiac operation. , 2002, The Annals of thoracic surgery.

[86]  M. Muñoz,et al.  Postoperative intravenous iron: a simple strategy to improve outcomes. , 2016, The Lancet. Haematology.

[87]  Hans Gombotz,et al.  Estimating the cost of blood: past, present, and future directions. , 2007, Best practice & research. Clinical anaesthesiology.

[88]  P. Meybohm,et al.  Patient Blood Management Implementation Strategies and Their Effect on Physicians' Risk Perception, Clinical Knowledge and Perioperative Practice - the Frankfurt Experience , 2015, Transfusion Medicine and Hemotherapy.

[89]  I. C. Tudor,et al.  Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[90]  T. Burnouf,et al.  Fibrin Sealant: Scientific Rationale, Production Methods, Properties, and Current Clinical Use , 1997, Vox sanguinis.

[91]  I. Chin-Yee,et al.  A retrospective study evaluating single‐unit red blood cell transfusions in reducing allogeneic blood exposure , 2005, Transfusion medicine.

[92]  K. Boffard,et al.  Intraoperative Blood Salvage in Penetrating Abdominal Trauma: a Randomised, Controlled Trial , 2006, World Journal of Surgery.

[93]  Laupacis,et al.  Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials , 1998, Transfusion medicine.

[94]  B. Singal,et al.  Does preoperative anemia adversely affect colon and rectal surgery outcomes? , 2011, Journal of the American College of Surgeons.

[95]  P. Perel,et al.  Tranexamic acid for trauma – Authors' reply , 2010, The Lancet.

[96]  Yi Wang,et al.  Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. , 2015, International journal of surgery.

[97]  H. Almodaimegh,et al.  The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. , 2013, The Journal of arthroplasty.

[98]  D. Spahn,et al.  Effects of Allogeneic Red Blood Cell Transfusions on Clinical Outcomes in Patients Undergoing Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis , 2012, Annals of surgery.

[99]  J. Sicklick,et al.  Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group , 2017, The American surgeon.

[100]  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2003 .

[101]  O. Habler,et al.  Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines , 2011, British journal of anaesthesia.

[102]  C. Mazer,et al.  Transfusion Triggers for Guiding RBC Transfusion for Cardiovascular Surgery: A Systematic Review and Meta-Analysis* , 2014, Critical care medicine.

[103]  L. Fleisher,et al.  Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial , 2015, The Lancet.

[104]  J. Wetterslev,et al.  Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis , 2015, BMJ : British Medical Journal.

[105]  F. Jamali,et al.  Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study , 2011, The Lancet.

[106]  N. Rosencher,et al.  Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe * , 2003, Transfusion.

[107]  K. Knight,et al.  Prevalence and outcomes of anemia in surgery: a systematic review of the literature. , 2004, The American journal of medicine.

[108]  D. M. Anthony,et al.  Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. , 2003, The Cochrane database of systematic reviews.

[109]  D. Mbanya Barriers and enablers to introducing comprehensive patient blood management in the hospital. , 2012, Biologicals : journal of the International Association of Biological Standardization.

[110]  P. Whiting,et al.  Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. , 2015, Health technology assessment.

[111]  M. Pescatori,et al.  Perioperative blood transfusions for the recurrence of colorectal cancer. , 2004, The Cochrane database of systematic reviews.

[112]  Regina M. Hardison,et al.  Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. , 2013, American heart journal.

[113]  R. Peto,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. , 2010, Lancet.

[114]  E. Mascha,et al.  The Association Between Preoperative Anemia and 30-Day Mortality and Morbidity in Noncardiac Surgical Patients , 2013, Anesthesia and analgesia.

[115]  A. Auerbach,et al.  Harms associated with single unit perioperative transfusion: retrospective population based analysis , 2015, BMJ : British Medical Journal.

[116]  M. Braga,et al.  Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. , 1992, The European journal of surgery = Acta chirurgica.

[117]  R. Poses,et al.  SEVERITY OF ANAEMIA AND OPERATIVE MORTALITY AND MORBIDITY , 1988, The Lancet.

[118]  J. Carson,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[119]  I. Pipinos,et al.  Preoperative Anemia Is an Independent Predictor of Postoperative Mortality and Adverse Cardiac Events in Elderly Patients Undergoing Elective Vascular Operations , 2012, Annals of surgery.

[120]  A. Shander,et al.  Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. , 2011, The oncologist.

[121]  A. Dahan,et al.  Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty , 2016, Vox Sanguinis.

[122]  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007 .

[123]  S. Bhandari Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice , 2011, Therapeutics and clinical risk management.

[124]  J. Semmens,et al.  A Programmatic Approach to Patient Blood Management - Reducing Transfusions and Improving Patient Outcomes , 2015 .

[125]  R. Gamelli,et al.  EFFECT OF TRANSFUSION ON OXYGEN TRANSPORT IN CRITICALLY ILL PATIENTS , 1996, Shock.

[126]  S. Anker,et al.  Systematic review and meta‐analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review , 2016, European journal of heart failure.

[127]  A. Brand,et al.  Immunomodulation and Allogeneic Blood Transfusion , 2008 .

[128]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.